Cone Health Cancer Center at Alamance Regional — Burlington, North Carolina

Cone Health Cancer Center at Alamance Regional is a clinical research site located in Burlington, North Carolina, United States 27215.

Crixeo Health Trust Score: 88/100 (GOOD). This profile has not yet been claimed by the site owner.

Cone Health Cancer Center at Alamance Regional has participated in 103 clinical trials with 49 currently active.

Therapeutic areas: Plasma Cell Myeloma, Stage IB Lung Non-Small Cell Carcinoma AJCC v7, Stage II Lung Non-Small Cell Cancer AJCC v7.

Sponsors: ECOG-ACRIN Cancer Research Group, National Cancer Institute (NCI), Alliance for Clinical Trials in Oncology.

Sponsor Feasibility Report

Trust Score: 88/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Cone Health Cancer Center at Alamance Regional?

Cone Health Cancer Center at Alamance Regional has a Crixeo Trust Score of 88/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Cone Health Cancer Center at Alamance Regional conducted?

Cone Health Cancer Center at Alamance Regional has 103 clinical trials on record, with 49 currently active. Their work covers Plasma Cell Myeloma, Stage IB Lung Non-Small Cell Carcinoma AJCC v7, Stage II Lung Non-Small Cell Cancer AJCC v7.

Is Cone Health Cancer Center at Alamance Regional accredited by Crixeo Health?

Yes — Cone Health Cancer Center at Alamance Regional holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Cone Health Cancer Center at Alamance Regional?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.